PortfoliosLab logoPortfoliosLab logo
ISIN
US00857U1079
CUSIP
00857U107
IPO Date
Apr 15, 2021

Highlights

Market Cap
$1.38B
Enterprise Value
$1.28B
EPS (TTM)
-$22.51
Total Revenue (TTM)
$5.82B
Gross Profit (TTM)
-$225.14M
EBITDA (TTM)
-$340.64M
Year Range
$7.48 - $94.71
Target Price
$24.50
ROA (TTM)
-24.82%
ROE (TTM)
-205.85%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


agilon health, inc.

Performance

AGL Performance Chart

agilon health, inc. (AGL) is up 380.3% since the beginning of the year. At $83 per share, AGL is trading 12.7% below its 52-week high of $95. Investors who bought $1,000 worth of AGL shares 5 years ago would now be looking at an investment worth $94.


Loading charts...

S&P 500 Index

Returns By Period

agilon health, inc. (AGL) has returned 380.33% so far this year and 45.73% over the past 12 months.


agilon health, inc.

1D
-4.67%
1M
206.98%
YTD
380.33%
6M
386.90%
1Y
45.73%
3Y*
-45.31%
5Y*
-37.68%
10Y*

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AGL Monthly Returns History

Based on dividend-adjusted daily data since Apr 15, 2021, AGL's average daily return is +0.02%, while the average monthly return is +3.20%. At this rate, an investment would double in approximately 1.8 years.

Historically, 44% of months were positive and 56% were negative. The best month was Apr 2026 with a return of +253.4%, while the worst month was Jan 2024 at -53.1%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 5 months.

On a daily basis, AGL closed higher 47% of trading days. The best single day was May 7, 2026 with a return of +117.8%, while the worst single day was Aug 5, 2025 at -51.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202620.84%-29.19%-46.31%253.35%230.16%-10.38%380.33%
202575.79%-6.59%38.78%-1.62%-47.89%3.60%-22.17%-28.49%-19.53%-22.67%-18.25%5.77%-63.75%
2024-53.07%4.07%-0.49%-9.84%14.55%3.81%5.35%-40.78%-3.68%-35.11%-18.04%-9.09%-84.86%
202334.82%-2.53%11.98%2.19%-18.09%-12.78%10.44%-7.47%0.23%1.35%-41.00%18.17%-22.24%
2022-38.59%21.95%25.37%-29.90%7.48%14.29%14.66%-16.98%12.70%-15.24%-11.54%-8.09%-40.22%
20211.71%13.99%12.88%-9.32%-4.87%-25.11%-6.52%-10.20%22.73%-12.90%

Benchmark Metrics

agilon health, inc. has an annualized alpha of -8.43%, beta of 0.97, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since April 16, 2021.

  • This stock participated in 202.64% of S&P 500 Index downside but only 18.16% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-8.43%
Beta
0.97
0.03
Upside Capture
18.16%
Downside Capture
202.64%

Return for Risk

Risk / Return Rank

AGL ranks 61 for risk / return — better than 61% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


AGL Risk / Return Rank: 6161
Overall Rank
AGL Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
AGL Sortino Ratio Rank: 7373
Sortino Ratio Rank
AGL Omega Ratio Rank: 7474
Omega Ratio Rank
AGL Calmar Ratio Rank: 5454
Calmar Ratio Rank
AGL Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for agilon health, inc. (AGL) and compare them to S&P 500 Index.


AGLBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.98

Sortino ratioReturn per unit of downside risk

-1.20

Omega ratioGain probability vs. loss probability

1.25

1.41

-0.15

Calmar ratioReturn relative to maximum drawdown

0.53

2.93

-2.40

Martin ratioReturn relative to average drawdown

0.79

13.52

-12.73

Dividends

Dividend History


agilon health, inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the agilon health, inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the agilon health, inc. was 99.27%, occurring on Mar 31, 2026. The portfolio has not yet recovered.

The current agilon health, inc. drawdown is 92.35%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-99.27%Mar 2026
4y 9mo
4y 11moJun 2021 - now
2021 correction2021
-12.99%May 2021
3d8d
11dMay 2021 - May 2021
2021 pullback2021
-9.56%Jun 2021
5d8d
13dJun 2021 - Jun 2021
2021 pullback2021
-5.62%Apr 2021
1d13d
14dApr 2021 - May 2021
2021 pullback2021
-3.23%Apr 2021
0s3d
3dApr 2021 - Apr 2021

Drawdown Indicators


AGLBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.27%

-56.78%

-42.49%

Max Drawdown (1Y)

Largest decline over 1 year

-86.98%

-9.10%

-77.88%

Max Drawdown (3Y)

Largest decline over 3 years

-98.50%

-18.90%

-79.60%

Max Drawdown (5Y)

Largest decline over 5 years

-99.27%

-25.43%

-73.84%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-92.35%

-0.74%

-91.61%

Average Drawdown

Average peak-to-trough decline

-67.78%

-10.72%

-57.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

58.05%

1.97%

+56.08%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of agilon health, inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how agilon health, inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AGL relative to other companies in the Medical Care Facilities industry. Currently, AGL has a P/S ratio of 0.2. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AGL in comparison with other companies in the Medical Care Facilities industry. Currently, AGL has a P/B value of 7.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with AGL

Add agilon health, inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with AGL